Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-May-24 7:21 PM View:  | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 20% 37.81K to 45.51K | |
| 19-May-23 4:40 PM View: | Collegium Pharmaceutical, Inc (COLL) | 18-May-23 | Grant | 9,792 | -- | -- | 35% 28.02K to 37.81K | |
| 27-Dec-22 7:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 27-Dec-22 | Option Exercise | 19,815 | $16.15 | $320,012.00 | 71% 28.02K to 47.84K | |
| 27-Dec-22 7:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 27-Dec-22 | Planned Option Sale | 19,815 | $23.73 | $470,253.00 | (41%) 47.84K to 28.02K | |
| 27-Dec-22 7:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 23-Dec-22 | Option Exercise | 4,989 | $16.15 | $80,572.40 | 18% 28.02K to 33.01K | |
| 27-Dec-22 7:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 23-Dec-22 | Planned Option Sale | 4,989 | $23.00 | $114,747.00 | (15%) 33.01K to 28.02K | |
| 27-Dec-22 7:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 22-Dec-22 | Option Exercise | 237 | $16.15 | $3,827.55 | < 1% 28.02K to 28.26K | |
| 27-Dec-22 7:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 22-Dec-22 | Planned Option Sale | 237 | $23.00 | $5,451.00 | (< 1%) 28.26K to 28.02K | |
| 21-Dec-22 7:28 PM View: | Collegium Pharmaceutical, Inc (COLL) | 21-Dec-22 | Option Exercise | 46,600 | $16.15 | $752,590.00 | 166% 28.02K to 74.62K | |
| 21-Dec-22 7:28 PM View: | Collegium Pharmaceutical, Inc (COLL) | 21-Dec-22 | Planned Option Sale | 46,600 | $23.11 | $1,076,930.00 | (62%) 74.62K to 28.02K | |
| 21-Dec-22 7:28 PM View: | Collegium Pharmaceutical, Inc (COLL) | 20-Dec-22 | Option Exercise | 33,758 | $16.15 | $545,192.00 | 120% 28.02K to 61.78K | |
| 21-Dec-22 7:28 PM View: | Collegium Pharmaceutical, Inc (COLL) | 20-Dec-22 | Planned Option Sale | 33,758 | $23.08 | $779,135.00 | (55%) 61.78K to 28.02K | |
| 21-Dec-22 7:28 PM View: | Collegium Pharmaceutical, Inc (COLL) | 19-Dec-22 | Option Exercise | 3,606 | $16.15 | $58,236.90 | 13% 28.02K to 31.63K | |
| 21-Dec-22 7:28 PM View: | Collegium Pharmaceutical, Inc (COLL) | 19-Dec-22 | Planned Option Sale | 3,606 | $23.04 | $83,082.20 | (11%) 31.63K to 28.02K | |
| 14-Dec-22 6:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 13-Dec-22 | Option Exercise | 161,687 | $15.10 | $2,441,400.00 | 577% 28.02K to 189.71K | |
| 14-Dec-22 6:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 13-Dec-22 | Planned Option Sale | 161,687 | $22.16 | $3,582,980.00 | (85%) 189.71K to 28.02K | |
| 14-Dec-22 6:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 12-Dec-22 | Option Exercise | 27,920 | $15.09 | $421,334.00 | 100% 28.02K to 55.94K | |
| 14-Dec-22 6:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 12-Dec-22 | Planned Option Sale | 27,920 | $22.01 | $614,519.00 | (50%) 55.94K to 28.02K | |
| 05-Oct-22 5:42 PM View: | Biohaven Ltd. (BHVN) | 03-Oct-22 | Payment of Exercise | 5,507 | $7.50 | $41,302.50 | (22%) 24.88K to 19.37K | |
| 05-Oct-22 5:42 PM View: | Biohaven Ltd. (BHVN) | 03-Oct-22 | Acquisition (other) | 1,660 | -- | -- | 100% 0 to 1.66K | |
| 05-Oct-22 5:42 PM View: | Biohaven Ltd. (BHVN) | 03-Oct-22 | Option Exercise | 23,217 | $3.13 | $72,728.80 | 1399% 1.66K to 24.88K | |
| 23-May-22 5:53 PM View: | Collegium Pharmaceutical, Inc (COLL) | 19-May-22 | Grant | 14,035 | -- | -- | 100% 13.99K to 28.02K | |
| 03-Jun-21 5:27 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Jun-21 | Grant | 13,700 | -- | -- | 39% 34.89K to 48.59K | |
| 24-May-21 5:19 PM View: | Collegium Pharmaceutical, Inc (COLL) | 20-May-21 | Grant | 9,941 | -- | -- | 246% 4.05K to 13.99K | |
| 17-Mar-21 4:03 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Mar-21 | Market Sale (Planned) | 50,075 | $25.30 | $1,266,770.00 | (93%) 54.12K to 4.05K | 2% |
| 12-Aug-20 4:05 PM View: | Collegium Pharmaceutical, Inc (COLL) | 11-Aug-20 | Market Sale (Planned) | 13,071 | $19.13 | $250,048.00 | (19%) 67.19K to 54.12K | 1% |
| 09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jun-20 | Grant | 13,700 | -- | -- | 65% 21.19K to 34.89K | |
| 22-May-20 4:25 PM View: | Collegium Pharmaceutical, Inc (COLL) | 20-May-20 | Grant | 4,047 | -- | -- | 5% 81.8K to 85.84K | |
| 22-May-20 4:25 PM View: | Collegium Pharmaceutical, Inc (COLL) | 20-May-20 | Payment of Exercise | 18,650 | $22.05 | $411,232.00 | (22%) 85.84K to 67.19K | 14% |
| 15-May-20 4:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 13-May-20 | Market Sale (Planned) | 19,254 | $21.63 | $416,421.00 | (19%) 101.05K to 81.8K | 13% |
| 12-Feb-20 4:22 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-20 | Payment of Exercise | 4,962 | $21.62 | $107,278.00 | (5%) 106.01K to 101.05K | 13% |
| 22-Jan-20 4:29 PM View: | Collegium Pharmaceutical, Inc (COLL) | 21-Jan-20 | Payment of Exercise | 787 | $21.56 | $16,967.70 | (< 1%) 402.09K to 401.3K | 12% |
| 22-Jan-20 4:29 PM View: | Collegium Pharmaceutical, Inc (COLL) | 21-Jan-20 | Option Exercise | 275,463 | $5.73 | $1,578,400.00 | 218% 126.62K to 402.09K | |
| 22-Jan-20 4:29 PM View: | Collegium Pharmaceutical, Inc (COLL) | 21-Jan-20 | Market Option Sale (Planned) | 275,463 | $21.93 | $6,042,040.00 | (69%) 401.3K to 125.84K | 14% |
| 22-Jan-20 4:29 PM View: | Collegium Pharmaceutical, Inc (COLL) | 21-Jan-20 | Market Sale (Planned) | 19,824 | $21.93 | $434,822.00 | (16%) 125.84K to 106.01K | 14% |
| 13-Aug-19 4:45 PM View: | Collegium Pharmaceutical, Inc (COLL) | 09-Aug-19 | Payment of Exercise | 4,779 | $11.24 | $53,716.00 | (4%) 131.4K to 126.62K | (68%) |
| 23-Jul-19 4:03 PM View: | Collegium Pharmaceutical, Inc (COLL) | 19-Jul-19 | Payment of Exercise | 667 | $10.35 | $6,903.45 | (< 1%) 132.07K to 131.4K | (82%) |
| 17-Jul-19 4:22 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Jul-19 | Market Sale (Planned) | 25,000 | $11.26 | $281,500.00 | (16%) 157.07K to 132.07K | (68%) |
| 19-Jun-19 6:05 PM View: | Collegium Pharmaceutical, Inc (COLL) | 17-Jun-19 | Market Sale (Planned) | 25,000 | $11.37 | $284,246.00 | (14%) 182.07K to 157.07K | (66%) |
| 10-Jun-19 4:04 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-19 | Grant | 13,700 | -- | -- | 183% 7.49K to 21.19K | |
| 17-May-19 4:04 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-May-19 | Market Sale (Planned) | 25,000 | $12.84 | $321,042.00 | (12%) 207.07K to 182.07K | (47%) |
| 13-May-19 5:01 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Conversion | 3,851 | -- | -- | 100% 0 to 3.85K | |
| 13-May-19 5:01 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Purchase | 2,500 | $10.00 | $25,000.00 | 65% 3.85K to 6.35K | |
| 30-Apr-19 8:52 AM View: | Collegium Pharmaceutical, Inc (COLL) | 25-Apr-19 | Grant | 4,707 | -- | -- | 2% 202.36K to 207.07K | |
| 17-Apr-19 4:24 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Apr-19 | Market Sale (Planned) | 25,000 | $15.09 | $377,366.00 | (11%) 227.36K to 202.36K | (25%) |
| 19-Mar-19 5:36 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Mar-19 | Market Sale (Planned) | 25,000 | $17.17 | $429,250.00 | (10%) 252.36K to 227.36K | (10%) |
| 20-Feb-19 4:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Feb-19 | Market Sale (Planned) | 25,000 | $14.81 | $370,224.00 | (9%) 277.36K to 252.36K | (27%) |
| 11-Feb-19 5:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 08-Feb-19 | Payment of Exercise | 7,851 | $14.39 | $112,976.00 | (3%) 285.21K to 277.36K | (31%) |
| 23-Jan-19 4:14 PM View: | Collegium Pharmaceutical, Inc (COLL) | 18-Jan-19 | Payment of Exercise | 787 | $15.76 | $12,403.10 | (< 1%) 286.0K to 285.21K | (20%) |
| 17-Jan-19 4:16 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Jan-19 | Market Sale (Planned) | 25,000 | $15.56 | $389,000.00 | (8%) 311.0K to 286.0K | (21%) |